The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of a trial were published. This comes…
Read More
The U.S. Patent and Trademark Office (USPTO) has issued a new patent granting IP rights for the novel composition of matter and methods of use on the psilocybin-based molecules series…
Read More
Enveric Biosciences (NASDAQ: ENVB) announced that the United States Patent and Trademark Office issued U.S. Patent No. 11,752,130, titled “Carboxylated Psilocybin Derivatives and Methods of Using,” pertaining to the Company’s…
Read More
https://www.benzinga.com/markets/cannabis/22/05/27124788/exclusive-nasdaq-listed-enveric-to-split-into-two-companies-one-for-cannabinoids-one-for-psyched
Read More
https://www.benzinga.com/general/biotech/22/04/26693851/exclusive-enveric-offers-investors-rare-exposure-to-both-cannabis-and-psychedelic-industries
Read More
https://endpts.com/inside-the-race-to-make-psychedelics-mainstream-medicines/
Read More
https://www.benzinga.com/markets/cannabis/22/03/26284541/five-companies-developing-second-generation-psychedelics-for-mental-health
Read More
https://psychedelichealth.co.uk/2022/02/21/trial-psychedelic-therapy-cancer-distress/
Read More
https://www.benzinga.com/markets/cannabis/22/02/25697576/psilocybin-for-cancer-related-distress-enveric-to-launch-clinical-trial-in-partnership-with-univ
Read More
